By Fineline Cube 
China-based independent clinic laboratory (ICL) service provider Adicon Holdings Ltd (HKG: 9860) announced the acquisition of Suzhou Youqin Medical Laboratory Co., Ltd. and Suzhou Yuande Weikang Biopharmaceutical Co. Ltd. This strategic move aims to expand Adicon’s diagnostic service portfolio and strengthen its market position in the healthcare sector.
Profile of Suzhou Youqin Medical Laboratory
Founded in 2017, Youqin Medical Laboratory has established itself as a leading company in hematological disease diagnosis in China. The company boasts a comprehensive MICM precision diagnosis platform for hematological tumors. Its diagnostic services cover a wide range of hematological diseases. This acquisition will enhance Adicon’s capabilities in providing specialized diagnostic solutions for hematological conditions.
Profile of Suzhou Yuande Weikang Biopharmaceutical
Established in 2014, Suzhou Yuande Weikang Biopharmaceutical has been engaged in the research and production of antiplatelet membrane glycoprotein autoantibody detection kits and flow cytometry fluorescence labeled antibody detection reagents. The addition of Yuande Weikang’s product lines will further diversify Adicon’s offerings and strengthen its position in the diagnostic reagents market.-Fineline Info & Tech